Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Avicanna Inc (AVCN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.350 0.000    0.00%
03/05 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 156,000
  • Bid/Ask: 0.345 / 0.350
  • Day's Range: 0.330 - 0.350
Type:  Equity
Market:  Canada
Avicanna 0.350 0.000 0.00%

Avicanna Inc Company Profile

 
Get an in-depth profile of Avicanna Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

124

Equity Type

ORD

Avicanna Inc. is a Canada-based commercial-stage biopharmaceutical company. The Company is engaged in cannabinoid research, development, and evidence-based products for the global medical and pharmaceutical market segments. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products and Pharmaceutical Pipeline. Its Medical Cannabis & Wellness Products are marketed under the RHO Phyto brand and are a line of pharmaceutical-grade cannabis products containing varying ratios of cannabidiol (CBD) and tetrahydrocannabinol (THC). Avicanna has created a pipeline of patent-pending drug candidates that are indication-specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders.

Contact Information

Address 480 University Avenue Suite 1502
Toronto, M5G 1V2
Canada
Phone -
Fax -

Top Executives

Name Age Since Title
Flavio Jose Zaclis - 2021 Independent Director
Aras Azadian - 2016 Co-Founder, CEO & Director
Daniel N. Sauder - - Member of Global Scientific Advisory Board
Mauricio Torres-Pradilla - - Member of Global Scientific Advisory Board
Eileen McCormack - 2022 Independent Director
Giancarlo Davila Char - 2018 Director
Max Jones - - Member of Global Scientific Advisory Board
Sheldon Inwentash 67 - Member of Business Advisory Board
Humberto Reynales - - Member of International Scientific Advisory Board
John McVicar 59 2021 Independent Director
Al Harrington - - Member of Business Advisory Board
Ori Tal - - Member of Business Advisory Board
Aline D. Masuda - - Member of Business Advisory Board
Jason A. Hobson 50 - Member of Business Advisory Board
Paul Fornazzari 56 2023 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AVCN Comments

Write your thoughts about Avicanna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email